Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis

Internal Medicine

Volumn 44, Issue 3, 2005, Pages 200-206

  Kadota, Jun Ichi ^b   Mukae, Hiroshi ^a   Mizunoe, Syunji ^b   Kishi, Kenji ^b   Tokimatsu, Issei ^b   Nagai, Hiroyuki ^b   Tomono, Kazunori ^a   Kohno, Shigeru ^a   Nasu, Masaru ^b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Bronchoalveolar lavage; Chronic small airway disease; Diffuse panbronchiolitis; Macrolide antibiotics; Surgical lung biopsy

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BRONCHIOLITIS; BRONCHOSCOPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; JAPAN; LONG TERM CARE; LOW DRUG DOSE; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; NEUTROPHILIA; OXYGEN TENSION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SMALL AIRWAY DISEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VITAL CAPACITY;

ADULT; BIOPSY; BRONCHIECTASIS; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; LUNG; MACROLIDES; MALE; NEUTROPHILS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 17744369092     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.200     Document Type: Article

References (28)

1. Homma H, Yamanaka A, Tanimoto S, et al. Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest 83: 63-69, 1983.
2. Izumi T. Diffuse panbronchiolitis. Chest 100: 596-597, 1991.
3. Poletti V, Patelli M, Poletti G, Bertanti T, Spiga L. Diffuse panbronchiolitis observed in an Italian. Chest 98: 515-516, 1990.
4. Randhawa P, Hoagland MH, Yousem SA. Diffuse panbronchiolitis in North America. Am J Surg Pathol 15: 43-47, 1991.
5. Homer RJ, Khoo L, Smith GJ. Diffuse panbronchiolitis in a Hispanic man with travel to Japan. Chest 107: 1176-1178, 1995.
6. Fitzgerald JE, King TE Jr, Lynch DA, Tuder RM, Schwarz MI. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med 154: 497-503, 1996.
7. Iwata M, Colby TV, Kitaichi M. Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations. Hum Pathol 25: 357-363, 1994.
8. Nishimura K, Kitaichi M, Izumi T, Itoh H. Diffuse panbronchiolitis: HRCT and pathologic findings. Radiology 184: 779-785, 1992.
9. Akira M, Kitatani F, Lee YS, et al. Diffuse panbronchiolitis: evaluation with high resolution CT. Radiology 168: 433-438, 1988.
10. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157: 1829-1832, 1998.
11. Ichikawa Y, Ninomiya H, Koga H, et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 146: 196-203, 1992.
12. Kadota J, Sakito O, Kohno S, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147: 153-159, 1993.
13. Poletti V, Chilosi M, Trisolini R, et al. Idiopathic bronchiolitis mimicking diffuse panbronchiolitis. Sarcoidosis Vasc Diffuse Lung Dis 20: 62-68, 2003.
14. Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: Clinical, functional, and HRCT findings. Am J Respir Crit Care Med 57: 1658-1665, 1998.
15. Homma S, Kawabata M, Kishi K, et al. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J 12: 444-452, 1998.
16. Hayakawa H, Sato A, Imokawa S, et al. Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease: similarities and differences. Intern Med 37: 504-508, 1998.
17. Ono K, Shimamoto Y, Matsuzaki M, et al. Diffuse panbronchiolitis as a pulmonary complication in patients with adult T-cell leukemia. Am J Hematol 30: 86-90, 1989.
18. Desai SJ, Gephardt GN, Stoller JK. Diffuse panbronchiolitis preceding ulcerative colitis. Chest 95: 1342-1344, 1989.
19. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K. Interleukin 1β, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: A potential mechanism of macrolide therapy. Respiration 63: 42-48, 1996.
20. Tamaoki J, Takeyama K, Tagaya E, Konno K. Effect of clarithromycin on sputum production and its theological properties in chronic respiratory tract infections. Antimicrob Agents Chemother 39 1688-1690, 1995.
21. Georgopoulas D, Anthonisen NR. Symptoms and signs of COPD. in: Chronic Obstructive Pulmonary Disease. Cherniack NS, Ed. WB Saunders Co, Toronto, 1991: 357-363.
22. Sugimoto M, Kitaichi M, Ikeda A, Nagai S, Izumi T. Chronic bronchioloalveolitis with human T-cell lymphotropic virus type I infection. Curr Opin Pul Res 4: 98-102, 1998.
23. Kadota J, Mukae H, Ishii H, et al. Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. Respir Med 97: 844-850, 2003.
24. Kadota J, Mukae H, Fujii T, Seki M, Tomono K, Kohno S. Clinical similarities and differences between human T-cell lymphotropic virus type-1-associated bronchiolitis and diffuse panbronchiolitis. Chest 125: 1239-1247, 2004.
25. Goswami SK, Kivity S, Marom Z. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 141: 72-78, 1990.
26. Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K. Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J 5: 234-238, 1992.
27. Kondo M, Kanoh S, Tamaoki J, Shirakawa H, Miyazaki S, Nagai A. Erythromycin inhibits ATP-induced intracellular calcium responses in bovine tracheal epithelial cells. Am J Respir Cell Mol Biol 19: 799-804, 1999.
28. Azuma A, Keicho N, Furukawa H, Yabe T, Kudoh S. Prolonged survival of a bare lymphocyte syndrome type I patient with diffuse panbronchiolitis treated with erythromycin. Sarcoidosis Vasc Diffuse Lung Dis 18: 312-313, 2001.